Table 4 Cox regression analysis for disease-free and overall survival in postmenopausal patients
Disease-free survival analysis | Overall survival analysis | |||||||
|---|---|---|---|---|---|---|---|---|
Univariate | Multivariate | Univariate | Multivariate | |||||
Variable | P | RR (95% CI) | P | RR (95% CI) | P | RR (95% CI) | P | RR (95% CI) |
Grading | 0.107 | 1.42 (0.93–2.17) | - | - | 0.015 | 1.81 (1.12–2.91) | 0.059 | 1.58 (0.98–2.56) |
Lymph node status | 0.05 | 1.97 (1.01–3.87) | - | - | 0.134 | 1.83 (0.83–4.05) | - | - |
Tumour size | 0.001 | 1.85 (1.27–2.7) | 0.003 | 1.79 (1.22–2.64) | 0.001 | 2.11 (1.38–3.23) | 0.002 | 1.97 (1.27–3.03) |
ER status | 0.774 | 1.12 (0.53–2.34) | - | - | 0.903 | 0.95 (0.4–2.24) | - | - |
PgR status | 0.19 | 0.65 (0.34–1.23) | - | - | 0.558 | 0.8 (0.37–1.7) | - | - |
FasL : Fas ratio | 0.01 | 2.29 (1.22–4.32) | 0.028 | 2.04 (1.08–3.85) | 0.187 | 1.65 (0.78–3.46) | - | - |